ADAGIO THERAPEUTICS, INC.

(ADGI)
  Rapport
Geschatte realtime Cboe BZX  -  21:46 08-08-2022
3.935 USD   -1.63%
05/07SECTOR UPDATE : Aandelen in de gezondheidszorg worstelen dinsdag
MT
05/07SECTOR UPDATE : Aandelen in de gezondheidszorg trekken zich terug in de dinsdaghandel
MT
05/07SECTOR UPDATE : Gezondheidszorg
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op ADAGIO THERAPEUTICS, INC.
23/02ADAGIO THERAPEUTICS : Announces David Hering Appointed Interim Chief Executive Officer - F..
23/02ADAGIO THERAPEUTICS, INC. : Change in Directors or Principal Officers, Other Events, Finan..
23/02Adagio Therapeutics Announces David Hering Appointed Interim Chief Executive Officer
23/02Adagio Therapeutics Announces David Hering Appointed Interim Chief Executive Officer
22/02ADAGIO THERAPEUTICS : Announces CEO Succession Plan - Form 8-K
22/02ADAGIO THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
22/02Adagio Therapeutics Announces ADG20 Development Plans and Pipeline Updates
22/02Adagio Therapeutics Announces ADG20 Development Plans and Pipeline Updates
22/02Adagio Therapeutics Announces ADG20 Development Plans and Pipeline Updates
19/02Adagio Therapeutics Announces CEO Succession Plan
19/02Adagio Therapeutics, Inc. Announces Executive Changes
18/02ADAGIO THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
10/02Adagio Therapeutics Shares Plummet Amid Lower-Than-Average Volumes
07/02Adagio Therapeutics Shares Rise in Monday Afternoon Trading; Volume Down
02/02Certain Common Stock of Adagio Therapeutics, Inc. are subject to a Lock-Up Agreement En..
02/02Certain Options of Adagio Therapeutics, Inc. are subject to a Lock-Up Agreement Ending ..
14/01Adagio Therapeutics resume actividad neutralizante de ADG20 contra variantes de SARS-Co..
14/01Adagio Therapeutics legt zusammenfassende Ergebnisse zur neutralisierenden Wirkung von ..
14/01Adagio Therapeutics résume l'activité neutralisante de l'ADG20 contre les variants du S..
13/01Wall Street Set for Narrow Gains; US Wholesale Prices Rise Less Than Expected in Decemb..
13/01Health Care Stocks Mixed Pre-Bell Thursday
13/01SECTOR UPDATE : Health Care
13/01ADAGIO THERAPEUTICS : Summarizes ADG20 Neutralizing Activity Against SARS-CoV-2 Variants a..
13/01ADAGIO THERAPEUTICS, INC. : Regulation FD Disclosure, Other Events, Financial Statements a..
13/01Top Premarket Gainers
13/01Adagio Therapeutics Reports Neutralization Activity Against Omicron in Phase 2/3 Clinic..
12/01Adagio Therapeutics Details Omicron-Related Efforts
12/01Adagio Therapeutics Summarizes ADG20 Neutralizing Activity Against SARS-CoV-2 Variants ..
12/01Adagio Therapeutics Summarizes ADG20 Neutralizing Activity Against SARS-CoV-2 Variants ..
12/01Adagio Therapeutics, Inc. Summarizes ADG20 Neutralizing Activity Against SARS-CoV-2 Var..
07/01NORTH AMERICAN MORNING BRIEFING : Stock Futures -2-
06/01Adagio Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
2021NORTH AMERICAN MORNING BRIEFING : Stocks to Rise -2-
2021Adagio Therapeutics Shares Fall After Jefferies Downgrade
2021ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) added to S&P Biotechnology Select Industry Inde..
2021ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) added to S&P Global BMI Index
2021Adagio Therapeutics Shares Soar in Midday Trading
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
2021MÄRKTE USA/Fest - Fed-Beschlüsse wie erwartet
2021MÄRKTE USA/Börse mit leichten Abgaben vor Fed-Entscheid
2021MÄRKTE USA/Wall Street mit leichten Abgaben vor Fed
2021MÄRKTE USA/Wall Street vor Wartemodus auf Fed
2021Health Care Trim Tuesday Retreat, Helped by Late Biotechs Recovery
2021Top Midday Decliners
2021Health Care Stocks Drifting Lower This Afternoon
2021SECTOR UPDATE : Health Care
2021Adagio Therapeutics annonce une réduction de l'activité neutralisante in vitro de l'ADG..
2021Adagio Therapeutics informa reducción en la actividad neutralizante in vitro de ADG20 c..
2021Adagio Therapeutics vermeldet eine verminderte neutralisierende Wirkung von ADG20 in vi..
2021Adagio Therapeutics vermeldet eine verminderte neutralisierende Wirkung von ADG20 in vi..
2021Health Care Stocks Decline Premarket Tuesday
2021ADAGIO THERAPEUTICS : Reports Reduction in In Vitro Neutralizing Activity of ADG20 Against..
2021Wall Street Tumbles Pre-Bell, Fed Meeting Eyed
2021ADAGIO THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (f..
2021Adagio Therapeutics Says Investigational COVID-19 Antibody Treatment Less Effective Aga..
2021Top Premarket Decliners
2021Adagio Therapeutics Reports Reduction in In Vitro Neutralizing Activity of ADG20 Agains..
2021Adagio Therapeutics Reports Reduction in Vitro Neutralizing Activity of ADG20 Against O..
2021Adagio Therapeutics informa de que ninguna de las mutaciones presentes en la variante ó..
2021Adagio Therapeutics meldet, dass keine der Mutationen der SARS-CoV-2-Variante Omikron i..
2021++ Analysen des Tages von Dow Jones Newswires (30.11.2021) +++
2021NORTH AMERICAN MORNING BRIEFING : -3-
2021HINTERGRUND/Hersteller bereiten Anpassung der Corona-Impfstoffe vor
2021Health Care Stocks Hanging On For Narrow Gains Near Monday Close
2021Health Care Stocks Rising Monday Afternoon
2021SECTOR UPDATE : Health Care
2021Top Midday Gainers
2021ADAGIO THERAPEUTICS : Reports That None of the Mutations Present in SARS-CoV-2 Variant, Om..
2021ADAGIO THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (f..
2021Top Premarket Gainers
2021Adagio Therapeutics Stock Surges Pre-Bell on Information Related to ADG20's Effectivene..
2021Adagio Therapeutics Reports That None of the Mutations Present in SARS-CoV-2 Variant, O..
2021Adagio Therapeutics Reports That None of the Mutations Present in SARS-CoV-2 Variant, O..
2021ADAGIO THERAPEUTICS : Announces Expansion of Management Team and Board of Directors to Sup..
2021ADAGIO THERAPEUTICS, INC. : Change in Directors or Principal Officers, Regulation FD Discl..
Vorig1   2  3Volgende